3

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: May 9, 2017
Period of Report: May 9, 2017
Accession Number: 0001553878-17-000011

View Document ↗ View on SEC.gov ↗